Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 22 04:00PM ET
87.62
Dollar change
+0.97
Percentage change
1.12
%
IndexS&P 500 P/E38.07 EPS (ttm)2.30 Insider Own1.58% Shs Outstand601.10M Perf Week1.84%
Market Cap52.69B Forward P/E28.30 EPS next Y3.10 Insider Trans-4.16% Shs Float591.78M Perf Month17.09%
Income1.40B PEG4.11 EPS next Q0.64 Inst Own83.41% Short Float1.68% Perf Quarter30.41%
Sales6.00B P/S8.77 EPS this Y9.75% Inst Trans-0.08% Short Ratio2.28 Perf Half Y15.33%
Book/sh11.06 P/B7.92 EPS next Y12.38% ROA15.89% Short Interest9.96M Perf Year15.98%
Cash/sh2.74 P/C31.97 EPS next 5Y9.26% ROE22.52% 52W Range60.57 - 94.87 Perf YTD14.91%
Dividend Est.- P/FCF81.96 EPS past 5Y15.35% ROI19.16% 52W High-7.64% Beta1.05
Dividend TTM- Quick Ratio2.40 Sales past 5Y10.28% Gross Margin76.04% 52W Low44.66% ATR (14)2.35
Dividend Ex-Date- Current Ratio3.38 EPS Y/Y TTM-6.00% Oper. Margin27.81% RSI (14)69.79 Volatility1.89% 3.11%
Employees19800 Debt/Eq0.10 Sales Y/Y TTM11.56% Profit Margin23.35% Recom2.17 Target Price91.92
Option/ShortYes / Yes LT Debt/Eq0.10 EPS Q/Q-5.72% Payout0.00% Rel Volume0.56 Prev Close86.65
Sales Surprise2.49% EPS Surprise0.42% Sales Q/Q13.78% EarningsFeb 06 AMC Avg Volume4.38M Price87.62
SMA206.34% SMA5012.67% SMA20012.08% Trades Volume2,460,721 Change1.12%
Date Action Analyst Rating Change Price Target Change
Feb-02-24Upgrade Wells Fargo Equal Weight → Overweight $94
Jan-04-24Downgrade Evercore ISI Outperform → In-line $80 → $77
Dec-11-23Downgrade Citigroup Buy → Neutral
Nov-28-23Downgrade Wolfe Research Peer Perform → Underperform $57
Sep-26-23Upgrade Oppenheimer Perform → Outperform $90
Jul-19-23Initiated Robert W. Baird Outperform $107
May-30-23Resumed Morgan Stanley Overweight $102
Mar-29-23Initiated UBS Neutral $84
Mar-08-23Downgrade Wells Fargo Overweight → Equal Weight $97 → $78
Feb-06-23Downgrade Raymond James Outperform → Mkt Perform
Feb-18-24 01:26PM
Feb-15-24 09:36AM
Feb-13-24 12:09AM
Feb-09-24 02:21AM
Feb-07-24 04:11PM
11:19AM Loading…
11:19AM
10:31AM
09:06AM
05:54AM
Feb-06-24 07:55PM
06:00PM
05:25PM
04:54PM
04:44PM
04:40PM
04:15PM Loading…
04:15PM
07:18AM
Feb-02-24 07:00AM
06:27AM
Feb-01-24 09:15AM
07:44AM
Jan-30-24 07:05AM
06:15AM
Jan-23-24 07:07AM
Jan-19-24 11:26AM
Jan-16-24 01:20AM
Jan-03-24 07:40AM
Jan-02-24 09:00AM
Dec-20-23 05:24AM
Dec-14-23 07:49PM
12:27PM Loading…
Dec-11-23 12:27PM
Dec-08-23 05:11AM
Dec-07-23 05:00PM
08:30AM
Nov-26-23 05:56AM
Nov-25-23 06:58AM
Nov-24-23 11:31AM
Nov-23-23 06:06AM
Oct-30-23 11:40AM
Oct-27-23 07:30AM
Oct-26-23 06:15PM
03:06PM
02:00PM
11:33AM
11:17AM
11:12AM
10:08AM
07:23AM
07:20AM
Oct-25-23 06:00PM
06:00PM
05:40PM
04:32PM
04:15PM
04:15PM
10:08AM
06:22AM
Oct-24-23 02:00PM
Oct-23-23 03:58AM
02:18AM
Oct-20-23 11:47AM
Oct-19-23 10:01AM
08:30AM
06:54AM
Oct-18-23 12:10PM
07:05AM
Oct-17-23 04:15PM
02:01PM
08:07AM
Oct-12-23 11:40AM
Oct-10-23 12:06PM
11:33AM
Oct-05-23 12:03PM
Sep-26-23 12:04PM
11:37AM
10:09AM
Sep-21-23 07:49PM
11:40AM
Sep-20-23 12:08PM
11:36AM
Sep-15-23 11:09AM
Sep-13-23 08:16AM
Sep-08-23 07:32PM
Sep-06-23 01:04PM
Sep-05-23 11:40AM
08:38AM
Aug-30-23 12:26PM
Aug-28-23 08:10AM
Aug-26-23 10:20AM
Aug-25-23 11:31AM
Aug-22-23 07:56AM
Aug-21-23 11:37AM
11:14AM
Aug-20-23 10:30AM
Aug-18-23 11:40AM
Aug-16-23 08:41AM
Aug-10-23 01:42PM
01:42PM
Aug-06-23 07:29AM
Aug-05-23 09:00AM
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chopra DaveenCVP, TMTTFeb 21Option Exercise59.267,000414,79730,950Feb 21 05:52 PM
Chopra DaveenCVP, TMTTFeb 21Sale86.748,200711,27222,750Feb 21 05:52 PM
Szyman Catherine M.CVP, Critical CareFeb 15Option Exercise36.7527,000992,25061,814Feb 15 05:25 PM
Szyman Catherine M.CVP, Critical CareFeb 15Sale85.6227,0002,311,65434,814Feb 15 05:25 PM
Szyman Catherine M.CVP, Critical CareFeb 13Option Exercise36.7520,000735,00054,814Feb 15 05:25 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentFeb 13Option Exercise36.7511,000404,25050,503Feb 13 04:51 PM
Szyman Catherine M.CVP, Critical CareFeb 13Sale86.4620,0001,729,20034,814Feb 15 05:25 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentFeb 13Sale85.8311,000944,15539,503Feb 13 04:51 PM
SELLERS ROBERT W.A.SVP, Corporate ControllerFeb 12Option Exercise36.7512,210448,71825,297Feb 12 05:44 PM
SELLERS ROBERT W.A.SVP, Corporate ControllerFeb 12Sale87.0012,2101,062,27013,087Feb 12 05:44 PM
STONE HEISZ LESLIEDirectorFeb 08Option Exercise36.867,056260,10734,036Feb 08 06:08 PM
STONE HEISZ LESLIEDirectorFeb 08Sale86.457,056609,99126,980Feb 08 06:08 PM
MUSSALLEM MICHAEL ADirectorFeb 05Option Exercise36.7529,3501,078,61233,836Feb 05 06:37 PM
MUSSALLEM MICHAEL ADirectorFeb 05Sale87.4929,3502,567,7544,486Feb 05 06:37 PM
Ullem Scott B.CVP, Chief Financial OfficerFeb 01Option Exercise36.757,255266,62126,503Feb 01 05:52 PM
Ullem Scott B.CVP, Chief Financial OfficerFeb 01Sale78.297,255567,99419,248Feb 01 05:52 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentJan 12Option Exercise36.7510,000367,50049,503Jan 12 05:36 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentJan 12Sale75.6710,000756,70039,503Jan 12 05:36 PM
MUSSALLEM MICHAEL ADirectorJan 05Option Exercise36.7529,3501,078,61233,836Jan 05 07:19 PM
MUSSALLEM MICHAEL ADirectorJan 05Sale72.9829,3502,142,0894,486Jan 05 07:19 PM
Ullem Scott B.CVP, Chief Financial OfficerDec 29Option Exercise36.7514,510533,24233,758Dec 29 04:25 PM
Ullem Scott B.CVP, Chief Financial OfficerDec 29Sale76.5514,5101,110,79419,248Dec 29 04:25 PM
Chopra DaveenCVP, TMTTDec 15Option Exercise59.267,000414,79730,950Dec 15 05:22 PM
Chopra DaveenCVP, TMTTDec 15Sale78.257,000547,72423,950Dec 15 05:22 PM
MUSSALLEM MICHAEL ADirectorDec 13Option Exercise36.7529,3501,078,61233,836Dec 13 07:04 PM
Wood Larry LGlobal President TAVR & SurgDec 13Option Exercise45.288,658392,006222,452Dec 13 07:04 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentDec 13Option Exercise36.758,000294,00047,503Dec 13 07:04 PM
MUSSALLEM MICHAEL ADirectorDec 13Sale74.6229,3502,190,0434,486Dec 13 07:04 PM
Wood Larry LGlobal President TAVR & SurgDec 13Sale71.868,658622,164213,794Dec 13 07:04 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentDec 13Sale71.868,000574,88039,503Dec 13 07:04 PM
Chopra DaveenCVP, TMTTDec 06Option Exercise59.263,500207,39827,450Dec 06 05:01 PM
Chopra DaveenCVP, TMTTDec 06Sale70.003,500245,00623,950Dec 06 05:01 PM
Wood Larry LGlobal President TAVR & SurgNov 13Option Exercise45.288,660392,096222,454Nov 13 05:21 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentNov 13Option Exercise36.756,000220,50045,503Nov 13 05:21 PM
Wood Larry LGlobal President TAVR & SurgNov 13Sale65.308,660565,460213,794Nov 13 05:21 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentNov 13Sale65.306,000391,78039,503Nov 13 05:21 PM
MUSSALLEM MICHAEL ADirectorNov 03Option Exercise36.7529,3501,078,61233,836Nov 06 06:33 PM
MUSSALLEM MICHAEL ADirectorNov 03Sale67.1829,3501,971,7334,486Nov 06 06:33 PM
Ullem Scott B.CVP, Chief Financial OfficerOct 31Option Exercise36.757,255266,62126,503Oct 31 05:22 PM
Ullem Scott B.CVP, Chief Financial OfficerOct 31Sale62.667,255454,56919,248Oct 31 05:22 PM
Wood Larry LGlobal President TAVR & SurgOct 13Option Exercise45.288,660392,096222,454Oct 13 05:02 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentOct 13Option Exercise36.755,000183,75044,503Oct 13 05:01 PM
Wood Larry LGlobal President TAVR & SurgOct 13Sale70.008,660606,198213,794Oct 13 05:02 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentOct 13Sale69.985,000349,90939,503Oct 13 05:01 PM
Szyman Catherine M.CVP, Critical CareOct 10Option Exercise36.755,000183,75039,814Oct 10 06:23 PM
Szyman Catherine M.CVP, Critical CareOct 10Sale72.685,000363,40034,814Oct 10 06:23 PM
Chopra DaveenCVP, TMTTOct 03Option Exercise59.268,500503,68232,450Oct 03 04:58 PM
Chopra DaveenCVP, TMTTOct 03Sale70.008,500595,00023,950Oct 03 04:58 PM
MUSSALLEM MICHAEL ADirectorOct 02Option Exercise36.7529,3501,078,61233,836Oct 02 06:51 PM
MUSSALLEM MICHAEL ADirectorOct 02Sale68.8429,3502,020,4544,486Oct 02 06:51 PM
Ullem Scott B.CVP, Chief Financial OfficerSep 29Option Exercise36.757,255266,62126,503Sep 29 04:49 PM
Ullem Scott B.CVP, Chief Financial OfficerSep 29Sale69.547,255504,52719,248Sep 29 04:49 PM
Wood Larry LGlobal President TAVR & SurgSep 14Option Exercise45.288,660392,096222,454Sep 14 08:00 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentSep 14Option Exercise36.754,500165,37544,003Sep 14 08:00 PM
Wood Larry LGlobal President TAVR & SurgSep 14Sale73.638,660637,615213,794Sep 14 08:00 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentSep 14Sale73.714,500331,69539,503Sep 14 08:00 PM
Szyman Catherine M.CVP, Critical CareSep 08Option Exercise36.755,000183,75039,814Sep 08 05:29 PM
Szyman Catherine M.CVP, Critical CareSep 08Sale76.005,000380,00034,814Sep 08 05:29 PM
Chopra DaveenCVP, TMTTSep 06Option Exercise59.268,500503,68232,450Sep 06 05:09 PM
Chopra DaveenCVP, TMTTSep 06Sale76.078,500646,60923,950Sep 06 05:09 PM
MUSSALLEM MICHAEL ADirectorSep 05Option Exercise36.7529,3501,078,61233,836Sep 05 07:08 PM
MUSSALLEM MICHAEL ADirectorSep 05Sale75.8629,3502,226,4914,486Sep 05 07:08 PM
Ullem Scott B.CVP, Chief Financial OfficerAug 31Option Exercise36.757,255266,62126,503Aug 31 05:34 PM
Ullem Scott B.CVP, Chief Financial OfficerAug 31Sale77.797,255564,36619,248Aug 31 05:34 PM
Chopra DaveenCVP, TMTTAug 29Sale76.691,500115,04023,950Aug 29 05:31 PM
Wood Larry LGlobal President TAVR & SurgAug 14Option Exercise45.286,421290,722220,215Aug 14 06:02 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentAug 14Option Exercise36.754,500165,37544,003Aug 14 06:02 PM
Wood Larry LGlobal President TAVR & SurgAug 14Sale79.306,421509,185213,794Aug 14 06:02 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentAug 14Sale79.304,500356,85039,503Aug 14 06:02 PM
STONE HEISZ LESLIEDirectorAug 10Sale78.873,303260,50926,980Aug 10 05:48 PM
Szyman Catherine M.CVP, Critical CareAug 09Option Exercise36.755,000183,75039,814Aug 09 05:44 PM
Szyman Catherine M.CVP, Critical CareAug 09Sale78.645,000393,18534,814Aug 09 05:44 PM
MUSSALLEM MICHAEL ADirectorAug 07Option Exercise36.7529,3501,078,61283,602Aug 07 07:20 PM
MUSSALLEM MICHAEL ADirectorAug 07Sale79.8729,3502,344,09554,252Aug 07 07:20 PM
Ullem Scott B.CVP, Chief Financial OfficerJul 31Option Exercise36.757,255266,62126,503Jul 31 05:23 PM
Ullem Scott B.CVP, Chief Financial OfficerJul 31Sale84.357,255611,95919,248Jul 31 05:23 PM
Wood Larry LGlobal President TAVR & SurgJul 14Option Exercise45.288,660392,096222,454Jul 14 05:58 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentJul 14Option Exercise36.753,500128,62543,003Jul 14 05:58 PM
Wood Larry LGlobal President TAVR & SurgJul 14Sale92.948,660804,843213,794Jul 14 05:58 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentJul 14Sale92.943,500325,27539,503Jul 14 05:58 PM
Szyman Catherine M.CVP, Critical CareJul 10Option Exercise36.755,000183,75039,814Jul 10 05:09 PM
Szyman Catherine M.CVP, Critical CareJul 10Sale90.525,000452,60034,814Jul 10 05:09 PM
MUSSALLEM MICHAEL ADirectorJul 05Option Exercise36.7529,3501,078,61283,602Jul 05 08:13 PM
MUSSALLEM MICHAEL ADirectorJul 05Sale90.7829,3502,664,48754,252Jul 05 08:13 PM
Ullem Scott B.CVP, Chief Financial OfficerJun 30Option Exercise36.757,255266,62126,503Jun 30 05:19 PM
Ullem Scott B.CVP, Chief Financial OfficerJun 30Sale93.277,255676,67419,248Jun 30 05:19 PM
Wood Larry LGlobal President TAVR & SurgJun 14Option Exercise45.288,660392,096222,454Jun 14 04:46 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentJun 14Option Exercise36.753,500128,62543,003Jun 14 04:46 PM
Wood Larry LGlobal President TAVR & SurgJun 14Sale90.158,660780,681213,794Jun 14 04:46 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentJun 14Sale89.773,500314,19539,503Jun 14 04:46 PM
Szyman Catherine M.CVP, Critical CareJun 13Option Exercise36.755,000183,75040,056Jun 13 08:59 PM
Szyman Catherine M.CVP, Critical CareJun 13Sale85.815,000429,04535,056Jun 13 08:59 PM
MUSSALLEM MICHAEL ADirectorJun 01Option Exercise36.7529,3501,078,612115,560Jun 01 08:11 PM
MUSSALLEM MICHAEL ADirectorJun 01Sale84.4629,3502,478,83986,210Jun 01 08:11 PM
Wood Larry LGlobal President TAVR & SurgMay 24Option Exercise45.286,421290,722220,215May 24 07:19 PM
Wood Larry LGlobal President TAVR & SurgMay 24Sale84.236,421540,841213,794May 24 07:19 PM
Ullem Scott B.CVP, Chief Financial OfficerMay 10Option Exercise35.2080,7002,840,37498,994May 11 06:11 PM
MUSSALLEM MICHAEL AChairman & CEOMay 10Option Exercise35.2029,3751,033,903111,100May 11 06:11 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentMay 10Option Exercise36.752,50091,87535,578May 11 06:15 PM
Ullem Scott B.CVP, Chief Financial OfficerMay 10Sale88.5480,7007,145,00418,294May 11 06:11 PM